Biocryst Pharmaceuticals Inc (BCRX)

SG&A Expenses

$337.33M

TTM · Period ending: · USD

BCRX logo

BCRX SG&A Expenses

Latest reported$337.33M
BCRX TTM SG&A Expenses ($1.90M → $337.33M)
High-resolution chart · PNG

BCRX sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biocryst Pharmaceuticals Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
337,325,000
360,732,000
348,647,000
333,336,000
315,406,000
289,272,000
266,294,000
250,206,000
235,770,000
225,518,000
213,894,000
199,665,000
185,936,000
172,956,000
159,371,000
144,605,000
142,678,000
130,986,000
118,818,000
104,417,000
86,620,000
74,178,000
67,929,000
57,432,000
51,972,000
46,748,000
37,121,000
31,122,000
27,310,000
28,143,000
29,514,000
29,722,000
25,142,000
18,484,000
13,933,000
11,796,000
11,209,000
11,099,000
11,253,000
11,413,000
11,388,000
12,198,000
13,047,000
12,374,000
11,455,000
9,934,000
7,461,000
6,683,000
6,208,000
5,426,000
5,220,000
5,879,000
6,247,000
6,625,000
7,024,000
6,150,000
7,727,000
10,121,000
12,342,000
14,666,581
15,177,581
14,383,581
14,178,581
14,446,187
13,717,187
12,821,187
11,481,187
10,210,227
9,617,227
9,970,227
10,399,227
10,508,962
10,632,962
9,979,962
9,465,962
8,610,373
7,614,373
6,985,373
6,108,373
5,946,323
5,142,323
4,485,323
3,686,323
3,115,316
3,048,316
3,247,316
3,211,316
3,439,000
3,237,000
2,864,000
2,811,000
2,245,804
2,374,804
2,692,804
2,853,804
3,301,089
3,335,089
3,329,089
3,300,089
3,237,256
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.